New clinical leads announced
The next four clinical leads have been announced to support the Institute’s key remit of improving patient care via large-scale clinically-driven projects.
Sotirios Bisdas, Clinical Lead:
“I am delighted to be appointed as clinical lead of the flagship program in neurooncology and together with Dr Cardoso lead an enthusiastic team of renowned researchers and clinicians at the forefront of the fight to defeat brain tumours. We are committed to enabling pioneering research to aid early diagnosis of brain tumours, to contribute to drug discovery or repurposing of existing drugs, to help personalise tumour treatment according to the individual needs of the patients, and eventually to increase survival rates and approach tumour cure. Our driving force is the synergistic effect between clinical neurology and neuroimaging with healthcare engineering at UCL/UCLH and our aspiration is to facilitate timely translation of novel technologies and discoveries for the patients’ benefit.”
Francesco D’Aiuto, Clinical Lead:
“I am delighted to be joining the Oral Health Flagship Programme with Ben. The next few years are going to be an exciting time in clinical dental/oral research and knowing that we will be able to work alongside such a great engineering team will increase our chances to develop innovative and effective treatment solutions for our patients.”
Ben Hanson, Engineering Lead:
“Very excited to be working with Francesco and colleagues. This programme will be creating new opportunities for clinical research, development of medical devices and diagnostic tools with very broad applications and impact.”
Prof Brian Davidson & Dr Kurinchi Gurusamy (Joint Clinical Leads):
“Dr Kurinchi Gurusamy brings his passion for evidence-based healthcare expertise in the field of HPB surgery (hepato-pancreato-biliary surgery) and hepatology to help improve the safety of surgery.
Prof Brian Davidson brings his surgical expertise and wealth of knowledge gained as a professor and consultant in the field of HPB surgery in order to implement surgical innovations in the operating theatre.”